Summary
- Quirónsalud Torrevieja hosted a scientific conference on pancreas cancer treatment.
- Over 100 health professionals participated to share knowledge and clinical experiences.
- The event focused on advances in surgical techniques, immunotherapy, and multidimensional patient care.
- experts highlighted the importance of personalized treatment in oncology.
- The conference was part of celebrations for the hospital’s 25th anniversary.
Innovations in Pancreatic Cancer Treatment Discussed at Quirónsalud torrevieja
On Thursday, Quirónsalud Torrevieja Hospital held a meaningful scientific event titled “Updates on the Management and Treatment of Pancreatic Cancer,” drawing over 100 healthcare professionals from various regions of the Valencia Community. This gathering served as a critical platform for updating knowledge and sharing clinical experiences related to one of the most complex oncological diseases, with the goal of enhancing the multidisciplinary approach to pancreatic cancer treatment.
Structure of the Event
The conference was divided into three thematic blocks, followed by an interactive roundtable discussing clinical case studies. Renowned experts in fields such as surgery, medical oncology, radiotherapy, imaging diagnostics, gastroenterology, nutrition, anesthesia, and mental health participated from leading institutions like the valencian institute of Oncology and the University Hospital of Valencia.
- Block 1: Focused on surgical diagnostics and treatments.
- Block 2: Addressed neoadjuvant and adjuvant therapies, including advancements in immunotherapy.
- Block 3: Discussed real clinical management challenges in pancreatic cancer care.
Key Insights from Experts
The event commenced with Dr. carlos Yago, Medical Director of Quirónsalud Torrevieja, emphasizing the importance of collaborative environments for sharing cutting-edge knowledge and fostering clinical coordination in tackling complex diseases like pancreatic cancer.
The first block featured discussions on cutting-edge surgical techniques, including robotics and 3D virtual modeling, which facilitate precise planning for surgical interventions. Dr. Pedro Bretcha, who moderated the session, stressed the evolving nature of pancreatic surgery due to technological advancements, allowing for safer and more complex resections.
Technological Advancements in surgery
Participants highlighted crucial elements such as:
- Conducting high-resolution CT scans to assess surgical candidacy.
- Utilizing endoscopic ultrasound and biopsies for tumor genetic analysis.
- Advantages of 3D modeling for individualized surgical strategies.
The second session,moderated by Dr. Antonio Brugarolas,focused on evolving neoadjuvant and adjuvant treatments and the increasing significance of precision oncology. Participants discussed molecular biology updates and the recent protocols in chemotherapy that aim for optimal tumor responses pre-surgery.Dr. Rosa Cañón remarked, “The current challenge in treating pancreatic cancer is to accurately select the most effective therapies for each patient. With precision medicine and the progress of new biomarkers, we are closer than ever to personalized treatments that significantly improve patient outcomes.”
Comprehensive Patient Care
The third block,led by Dr. Enrique de Madaria, spotlighted the integral management of real-world issues faced by pancreatic cancer patients. Notable experts like Dr. Pablo Pabón and Dr.Nuria Javaloyes discussed the vital role of holistic care beyond oncology treatment, which encompasses pain management, nutritional support, and emotional health.
“Incorporating nutrition,pain relief,and emotional support into the therapeutic plan is as crucial as chemotherapy or surgery,” stated Dr. Madaria.
The event concluded with an interactive roundtable analyzing real clinical cases, encouraging active participation and enhancing collaborative decision-making among professionals.
Hospital Commemoration and future Directions
Closing remarks were made by Dr. Ana Segura, Vice President of the Official College of Physicians of Alicante, congratulating Quirónsalud Torrevieja for the scientific quality and institution of the event, which was part of the hospital’s 25th-anniversary celebrations.
Quirónsalud remains at the forefront of healthcare in the Valencia Community and murcia, with a commitment to technological innovation and comprehensive patient-centered care. The hospital’s initiatives reflect a dedication to advancing medical science and improving patient outcomes, amidst evolving challenges in oncology.
For more details, visit Quirónsalud’s official website.